The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension

Thyroid

Volumn 22, Issue 11, 2012, Pages 1144-1152

  Randolph, Gregory W ^a   Duh, Quan Yang ^b   Heller, Keith S ^c   Livolsi, Virginia A ^d   Mandel, Susan J ^d   Steward, David L ^e   Tufano, Ralph P ^f   Tuttle, R Michael ^g  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^f JOHNS HOPKINS HOSPITAL   (United States)

^g MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CERVICAL LYMPH NODE; DISEASE SPECIFIC SURVIVAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LOCAL RECURRENCE FREE SURVIVAL; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; NECK DISSECTION; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; THYROID PAPILLARY CARCINOMA; THYROIDECTOMY;

CARCINOMA; CARCINOMA, PAPILLARY; HUMANS; LYMPHATIC METASTASIS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; RISK; THYROID NEOPLASMS;

EID: 84869068913     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2012.0043     Document Type: Review

References (56)

1. Hughes DT, White ML, Miller BS, Gauger PG, Burney RE, Doherty GM 2010 Influence of prophylactic central lymph node dissection on postoperative thyroglobulin levels and radioiodine treatment in papillary thyroid cancer. Surgery 148:1100-1106; discussion 1106-1107.
2. Shindo M, Wu JC, Park EE, Tanzella F 2006 The importance of central compartment elective lymph node excision in the staging and treatment of papillary thyroid cancer. Arch Otolaryngol Head Neck Surg 132:650-654. (Pubitemid 43927043)
3. Pereira JA, Jimeno J, Miquel J, Iglesias M, Munne A, Sancho JJ, Sitges-Serra A 2005 Nodal yield, morbidity, and recurrence after central neck dissection for papillary thyroid carcinoma. Surgery 138:1095-1100; discussion 1100-1101.
4. Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, Mazzaferri EL, McIver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM 2009 Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 19:1167-1214.
5. Bonnet S, Hartl D, Leboulleux S, Baudin E, Lumbroso JD, Al Ghuzlan A, Chami L, Schlumberger M, Travagli JP 2009 Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. J Clin Endocrinol Metab 94:1162-1167.
6. Tuttle RM, Tala H, Shah J, Leboeuf R, Ghossein R, Gonen M, Brokhin M, Omry G, Fagin JA, Shaha A 2010 Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new american thyroid association staging system. Thyroid 20:1341-1349.
7. Ries LAG, Young JL, Keel GE, Eisner MP, Lin YD, Horner MJ 2007 SEER Survival Monograph: Cancer Survival Among Adults: U.S. SEER Program, 1988-2001, Patient and Tumor Characteristics. National Institute of Health, Bethesda, MD.
8. .Wada N, Duh QY, Sugino K, Iwasaki H, Kameyama K, Mimura T, Ito K, Takami H, Takanashi Y 2003 Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection. Ann Surg 237:399-407. (Pubitemid 38176456)
9. .Wada N, Masudo K, Nakayama H, Suganuma N, Matsuzu K, Hirakawa S, Rino Y, Masuda M, Imada T 2008 Clinical outcomes in older or younger patients with papillary thyroid carcinoma: impact of lymphadenopathy and patient age. Eur J Surg Oncol 34:202-207.
10. .Bardet S, Malville E, Rame JP, Babin E, Samama G, De Raucourt D, Michels JJ, Reznik Y, Henry-Amar M 2008 Macroscopic lymph-node involvement and neck dissection predict lymph-node recurrence in papillary thyroid carcinoma. Eur J Endocrinol 158:551-560. (Pubitemid 351606351)
11. .Yamashita H, Noguchi S, Murakami N, Kawamoto H, Watanabe S 1997 Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80: 2268-2272. (Pubitemid 28007398)
12. .Cranshaw IM, Carnaille B 2008 Micrometastases in thyroid cancer. An important finding? Surg Oncol 17:253-258.
13. .Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2004 Preoperative ultrasonographic examination for lymph node metastasis: usefulness when designing lymph node dissection for papillary microcarcinoma of the thyroid. World J Surg 28:498-501. (Pubitemid 38668483)
14. .Gemsenjager E, Perren A, Seifert B, Schuler G, Schweizer I, Heitz PU 2003 Lymph node surgery in papillary thyroid carcinoma. J Am Coll Surg 197:182-190. (Pubitemid 36927380)
15. .Ito Y, Fukushima M, Tomoda C, Inoue H, Kihara M, Higashiyama T, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Miyauchi A 2009 Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment. Endocr J 56:759-766.
16. Ito Y, Jikuzono T, Higashiyama T, Asahi S, Tomoda C, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2006 Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe. World J Surg 30:1821-1828. (Pubitemid 44454993)
17. Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2005 Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma. World J Surg 29:917-920. (Pubitemid 41800728)
18. .Moreno MA, Agarwal G, de Luna R, Siegel ER, Sherman SI, Edeiken-Monroe BS, Clayman GL 2011 Preoperative Lateral Neck Ultrasonography as a Long-term Outcome Predictor in Papillary Thyroid Cancer. Arch Otolaryngol Head Neck Surg 137:157-162.
19. .Sugitani I, Kasai N, Fujimoto Y, Yanagisawa A 2004 A novel classification system for patients with PTC: Addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period. Surgery 135:139-148. (Pubitemid 38130764)
20. .Leboulleux S, Rubino C, Baudin E, Caillou B, Hartl DM, Bidart JM, Travagli JP, Schlumberger M 2005 Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and/or tumor extension beyond the thyroid capsule at initial diagnosis. J Clin Endocrinol Metab 90:5723-5729. (Pubitemid 41415482)
21. .Hay ID, Hutchinson ME, Gonzalez-Losada T, McIver B, Reinalda ME, Grant CS, Thompson GB, Sebo TJ, Goellner JR 2008 Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period. Surgery 144:980-987; discussion 987-988.
22. .Ito Y, Miyauchi A 2007 A therapeutic strategy for incidentally detected papillary microcarcinoma of the thyroid. Nat Clin Pract Endocrinol Metab 3:240-248.
23. .Lee X, Gao M, Ji Y, Yu Y, Feng Y, Li Y, Zhang Y, Cheng W, Zhao W 2009 Analysis of differential BRAF(V600E) mutational status in high aggressive papillary thyroid microcarcinoma. Ann Surg Oncol 16:240-245.
24. .Lim DJ, Baek KH, Lee YS, Park WC, Kim MK, Kang MI, Jeon HM, Lee JM, Yun-Cha B, Lee KW, Son HY, Kang SK 2007 Clinical, histopathological, and molecular characteristics of papillary thyroid microcarcinoma. Thyroid 17:883-888.
25. .Mazzaferri EL 2007 Management of low-risk differentiated thyroid cancer. Endocr Pract 13:498-512.
26. .Park YJ, Kim YA, Lee YJ, Kim SH, Park SY, Kim KW, Chung JK, Youn YK, Kim KH, Park do J, Cho BY 2010 Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAF(V600E) mutation, clinicopathological features, and immunohistochemical findings. Head Neck 32:38-45.
27. .Ross DS, Litofsky D, Ain KB, Bigos T, Brierley JD, Cooper DS, Haugen BR, Jonklaas J, Ladenson PW, Magner J, Robbins J, Skarulis MC, Steward DL, Maxon HR, Sherman SI 2009 Recurrence after treatment of micropapillary thyroid cancer. Thyroid 19:1043-1048.
28. .Roti E, Rossi R, Trasforini G, Bertelli F, Ambrosio MR, Busutti L, Pearce EN, Braverman LE, Degli Uberti EC 2006 Clinical and histological characteristics of papillary thyroid microcarcinoma: results of a retrospective study in 243 patients. J Clin Endocrinol Metab 91:2171-2178. (Pubitemid 43855001)
29. .Noguchi M, Hashimoto T, Ohyama S, Tajiri K, Fujii H, Miyazaki I 1987 Indications for bilateral neck dissection in well-differentiated carcinoma of the thyroid. Jpn J Surg 17:439-444.
30. .Noguchi M, Yamada H, Ohta N, Ishida T, Tajiri K, Fujii H, Miyazaki I 1987 Regional lymph node metastases in welldifferentiated thyroid carcinoma. Int Surg 72:100-103. (Pubitemid 17115151)
31. .Noguchi S, Murakami N 1987 The value of lymph-node dissection in patients with differentiated thyroid cancer. Surg Clin North Am 67:251-261.
32. .Mirallie E, Visset J, Sagan C, Hamy A, Le Bodic MF, Paineau J 1999 Localization of cervical node metastasis of papillary thyroid carcinoma. World J Surg 23:970-973; discussion 973-974.
33. .Qubain SW, Nakano S, Baba M, Takao S, Aikou T 2002 Distribution of lymph node micrometastasis in pN0 welldifferentiated thyroid carcinoma. Surgery 131:249-256. (Pubitemid 34229777)
34. .So YK, Son YI, Hong SD, Seo MY, Baek CH, Jeong HS, Chung MK 2010 Subclinical lymph node metastasis in papillary thyroid microcarcinoma: A study of 551 resections. Surgery 148:526-531.
35. .Roh JL, Kim JM, Park CI 2008 Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis. Ann Surg Oncol 15:2482-2486.
36. .Vergez S, Sarini J, Percodani J, Serrano E, Caron P 2010 Lymph node management in clinically node-negative patients with papillary thyroid carcinoma. Eur J Surg Oncol 36:777-782.
37. .Noguchi S, Noguchi A, Murakami N 1970 Papillary carcinoma of the thyroid. II. Value of prophylactic lymph node excision. Cancer 26:1061-1064.
38. Baudin E, Travagli JP, Ropers J, Mancusi F, Bruno-Bossio G, Caillou B, Cailleux AF, Lumbroso JD, Parmentier C, Schlumberger M 1998 Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience. Cancer 83:553-559. (Pubitemid 28354512)
39. Chow SM, Law SC, Chan JK, Au SK, Yau S, Lau WH 2003 Papillary microcarcinoma of the thyroid-Prognostic significance of lymph node metastasis and multifocality. Cancer 98:31-40. (Pubitemid 36741122)
40. .Giordano D, Gradoni P, Oretti G, Molina E, Ferri T 2010 Treatment and prognostic factors of papillary thyroid microcarcinoma. Clin Otolaryngol 35:118-124.
41. Hay ID 2007 Management of patients with low-risk papillary thyroid carcinoma. Endocr Pract 13:521-533.
42. Ito Y, Uruno T, Nakano K, Takamura Y, Miya A, Kobayashi K, Yokozawa T, Matsuzuka F, Kuma S, Kuma K, Miyauchi A 2003 An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid. Thyroid 13:381-387. (Pubitemid 36588523)
43. Noguchi S, Yamashita H, Uchino S, Watanabe S 2008 Papillary microcarcinoma. World J Surg 32:747-753.
44. Yamashita H, Noguchi S, Murakami N, Toda M, Uchino S, Watanabe S, Kawamoto H 1999 Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma. Cancer 86:842-849. (Pubitemid 29399925)
45. Zetoune T, Keutgen X, Buitrago D, Aldailami H, Shao H, Mazumdar M, Fahey TJ, 3rd, Zarnegar R 2010 Prophylactic central neck dissection and local recurrence in papillary thyroid cancer: A meta-analysis. Ann Surg Oncol 17:3287- 3293.
46. Ito Y, Miyauchi A, Inoue H, Fukushima M, Kihara M, Higashiyama T, Tomoda C, Takamura Y, Kobayashi K, Miya A 2010 An Observational Trial For Papillary Thyroid Microcarcinoma In Japanese Patients. World J Surg 34:28-35
47. .Sugitani I, Toda K, Yamada K, Yamamoto N, Ikenaga M, Fujimoto Y 2010 Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg 34:1222-1231.
48. .Sywak M, Cornford L, Roach P, Stalberg P, Sidhu S, Delbridge L 2006 Routine ipsilateral level VI lymphadenectomy reduces postoperative thyroglobulin levels in papillary thyroid cancer. Surgery 140:1000-1005; discussion 1005-1007.
49. .Tollefsen HR, Shah JP, Huvos AG 1972 Papillary carcinoma of the thyroid. Recurrence in the thyroid gland after initial surgical treatment. Am J Surg 124:468-472.
50. .Rondeau G, Fish S, Hann LE, Fagin JA, Tuttle RM Ultrasonographically detected small thyroid bed nodules identified after total thyroidectomy for differentiated thyroid cancer seldom show clinically significant structural progression. Thyroid 21:845-853.
51. .Hwang HS, Orloff LA 2011 Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope 121:487-491.
52. .Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2006 Minimal extrathyroid extension does not affect the relapse-free survival of patients with papillary thyroid carcinoma measuring 4 cm or less over the age of 45 years. Surg Today 36:12-18. (Pubitemid 43015848)
53. .Moreno MA, Edeiken-Monroe BS, Siegel ER, Sherman SI, Clayman GL 2012 In papillary thyroid cancer, preoperative central neck ultrasound detects only macroscopic surgical disease, but negative findings predict excellent long-term regional control and survival. Thyroid 22:347-355.
54. .Ito Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2006 Clinical significance of metastasis to the central compartment from papillary microcarcinoma of the thyroid. World J Surg 30:91-99. (Pubitemid 43081619)
55. .Ito Y, Higashiyama T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K, Miyauchi A 2007 Risk factors for recurrence to the lymph node in papillary thyroid carcinoma patients without preoperatively detectable lateral node metastasis: validity of prophylactic modified radical neck dissection. World J Surg 31:2085-2091. (Pubitemid 47620236)
56. .Beal SH, Chen SL, Schneider PD, Martinez SR 2010 An evaluation of lymph node yield and lymph node ratio in well-differentiated thyroid carcinoma. Am Surg 76:28-32.